Ayee Argento: Ayyeka Between the Founders' Deal and the 14% Loan
Argento's founders' deal buys a staged control path into Ayyeka for $5 million, but the NIS 8.75 million bridge loan at 14% and the delayed New York project show that the real test is not the DCF headline but whether value can actually turn into cash.
What This Follow-up Is Testing
The main article argued that the central gap at Ayee Argento is not between portfolio value and market value, but between value booked on paper and cash that can actually be reached. This continuation isolates Ayyeka because that is where the gap becomes concrete. Ayyeka is the largest holding, but it is also where three developments now sit on top of each other: the delay in the New York project, a NIS 8.75 million loan priced at a 14% annual rate, and a founders' deal under which Argento is buying roughly 36% of Ayyeka for $5 million in five tranches.
The numbers alone explain why this deserves a standalone piece. Ayyeka's fair value in the partnership's books stood at NIS 21.838 million at year-end 2025, about 70.3% of the value of the three portfolio holdings. Against that, on April 6, 2026, the partnership's market cap was only about NIS 5.7 million. When one asset is that large relative to the entire public wrapper, the real question is no longer whether Ayyeka is interesting. The question is whether its value can actually move through all the intermediate layers, control, debt, collateral, FX and time, before it erodes.
That is the core thesis here. The founders' deal improves Argento's path to control at Ayyeka, but it does not yet create accessible value for public unitholders. The 14% loan buys time, but at a price that shows how tight the interim period already was. And the valuation that supports most of the portfolio's carrying value still requires a steep leap, from revenue of $3.213 million in 2025 to $15 million already in 2026. So the real issue is not whether Ayyeka is worth more on paper. It is how much of that value is actually executable.
The Founders' Deal Buys Control, Not Realization
On March 15, 2026, Ayee Argento Ltd. completed an agreement to acquire most of the shares and rights held by Ayyeka's founders and their families, except for 100,000 ordinary shares that remain with the founders. The acquired rights represent about 36% of Ayyeka's fully diluted equity. The consideration is $5 million, paid in five $1 million tranches, with each additional tranche due within 150 days of the prior one.
| Item | What was agreed | Why it matters |
|---|---|---|
| Rights being acquired | About 36% of fully diluted equity, except for 100,000 ordinary shares retained by the founders | This is large enough to reshape the balance of power at Ayyeka |
| Purchase price | $5 million | The deal is meaningful relative to the holding structure, but far below the DCF headline |
| Payment structure | Five $1 million tranches, up to 150 days apart | This is a staged acquisition, not a clean one-shot closing |
| What Argento already received after the first tranche | Joint notices to dismiss the claims, a proxy for an Argento director, and a voting agreement with the founders | Argento gains immediate influence before full payment is complete |
| What happens if payments stop | The proxy is cancelled if one of the next tranches is not paid, and the founders have a rescission remedy if the first three tranches are not completed | The new control structure still depends on ongoing payment capacity |
| Collateral | A pledge over the rights acquired in the first tranche, plus 12,011 Series B preferred shares and Ayyeka options | The sellers did not rely on promises alone, they took real security |
The first thing this deal says is that the private market in which control is changing hands is moving at a very different pace from the DCF. On a straight arithmetic basis, paying $5 million for roughly 36% of Ayyeka implies an equity value of about $13.9 million. That is nowhere near the $63.647 million company value used in the year-end DCF. The two numbers are not perfectly comparable because the founders' deal comes with litigation, staged payments, rescission mechanics and collateral. But that is exactly why the gap matters. The DCF describes what Ayyeka could be worth if the future path works. The founders' deal shows the price at which a large block can actually be bought in a pressured interim period.
The second point is structural. This control transaction sits at the level of Ayee Argento Ltd., not at the level of the public partnership itself. That is a material distinction. Note 5 says the partnership has no right to appoint directors at Ayyeka and, in its own assessment, does not have material influence there. At the same time, Ayyeka's own disclosure says that Yiftach Yaakov serves as Ayyeka's chairman and temporary CFO on behalf of Argento. So practical control is tightening through the broader Argento group, but that still does not automatically equal accessible value for the public unitholders. What is being bought first here is the ability to align the voting structure and reduce friction, not cash moving upstream.
In other words, the founders' deal can absolutely improve governance at Ayyeka. It may also remove part of the legal and managerial noise that has been hanging over the asset since 2023. But this is financed control, paid in stages, with rescission rights and collateral in favor of the sellers. It does not solve the realization question. It only changes the starting conditions from which Argento will try to realize value later.
The 14% Loan Puts a Price on Time
On September 4, 2025, Ayyeka signed a NIS 8.75 million loan with a third party for 12 months, at a fixed annual interest rate of 14% paid quarterly, with principal due at maturity. The loan is secured by a pledge over Ayyeka's rights to customer payments and backed by a full guarantee from Ayee Argento Ltd. for all of Ayyeka's obligations to the lender.
This is not ordinary debt raised by a company already sitting on a stable commercialization path. It is a bridge. The annual interest burden alone is about NIS 1.225 million. And the fact that the lender demanded both customer-payment collateral and a full Argento guarantee shows that the financing was not anchored in a technology story. It was anchored in the nearest cash flows that could be seized if the plan slipped.
To understand why that loan was needed, the key 2025 operating numbers need to be read together. Ayyeka's revenue fell to $3.213 million, from $4.128 million in 2024 and $4.344 million in 2023. Gross margin improved to 60.1%, but operating expenses climbed to $4.128 million and operating loss widened to $2.199 million. The valuation report attributes the revenue decline to a significant delay in a major New York project, with cash flow from that project expected, according to the valuation, only in 2026.
That is the critical point. The loan did not buy time on the way to a calm, already-proven commercialization ramp. It bought time until a major project, which still had not translated into cash in 2025, was expected to start paying. So the real question is not whether 14% is expensive. It is whether the gap between future value and present cash was large enough to force external financing against existing customer-related assets.
The board report adds the crucial second layer. Based on information provided to the partnership, a private fund managed by the controlling owners of the general partner transferred $1.7 million into Ayyeka during 2025. From October 2025, Ayyeka started cutting payroll and other costs. As of January 1, 2026, it was already described as cash-flow balanced between current operating expenses and current revenue, and additional cuts were made during the first quarter of 2026. On the one hand, that means the company did manage to stop the bleeding. On the other hand, the same disclosure says Ayyeka is working to raise funds in order to reduce its debt load, including repayment of this very loan.
So even the most supportive version of management's read is not that the issue has been solved. It is something narrower and more important: the current business may be able to carry itself after a sharp cost reset, but the debt layer is still too heavy and still needs new capital. That is a major difference. Operating breakeven is not the same thing as being able to refinance or repay expensive bridge debt.
The DCF Sees a Plausible Future, but It Still Requires an Aggressive Leap
The valuation sets Ayee Argento's holding in Ayyeka at $6.846 million as of December 31, 2025, up from $6.43 million a year earlier. That looks surprising at first glance because 2025 was the weaker revenue year. But the explanation for the increase is exactly where the real story sits.
The valuation summary says that the delay in the New York project was fully offset by an expected increase in long-term operating margins. At the same time, because the company missed its earlier forecasts, the specific company risk was increased by two percentage points versus the prior valuation. Even so, company value remained broadly unchanged, while the value of the holding also benefited from a material reduction in employee options during the second half of 2025.
That matters because it means the higher value did not come from a stronger 2025 P&L. It came from two other sources: a more optimistic long-term margin story and a better per-share capital structure. There is nothing inherently improper in that. But it is a reminder that Ayyeka's large carrying value still rests much more on what is supposed to happen than on what has already been delivered.
The model itself is explicit about that. It uses a 26.9% discount rate, states directly that the company depends on raising additional funds to continue operating, and adds a 10% specific risk premium on that basis. Even after doing that, it still assumes revenue jumps from $3.213 million in 2025 to $15 million in 2026, and eventually to $113.69 million in 2033. It also assumes operating margin reaches 35.9% by 2031.
This is not a gentle growth curve. It is a phase change. For the model to work, Ayyeka does not just need to deliver one New York project. It needs to prove that the project opens the door to a category of large, repeatable and continuing projects, that it can fund the working capital and installation cycle around them, and that after the expensive interim period there is still enough operating margin left to support a value above $60 million.
That is exactly where the founders' deal and the 14% loan intersect. The founders' deal says Argento wants more control before that path fully opens. The loan says the company already needed expensive external time to get there. The DCF says the value will be there if all of this works. But for now, the three documents together do not show value already realized. They show value that still has to be proven.
Even If Ayyeka Delivers, Public Holders Still Sit Behind One More Layer
There is one more point that is easy to miss. The partnership's FX exposure is tied mainly to its holdings in Tuqqi and Ayyeka, as well as to its dollar-linked bonds. As of December 31, 2025, the partnership had a net surplus of dollar financial assets over dollar financial liabilities of about NIS 39.272 million, and it had no forward contracts or hedging transactions in place. The sensitivity analysis says that a 5% move in the dollar exchange rate would change pretax profit by about NIS 1.679 million.
That matters here because if the New York project finally starts turning into cash, that should help Ayyeka as an operating company. But at the public-partnership level, even after operating execution improves, part of the path to reported value will still run through FX translation. So even an investor who believes in Ayyeka's business story has to remember that the public line is not just a function of commercialization. It is also a function of currency, with no hedge in place.
In practical terms, Ayyeka's value still has to pass through three layers before it becomes public value. First, the growth path embedded in the model has to be executed. Second, the expensive interim debt has to be serviced, refinanced or reduced. And only then can the new control structure, acquired in stages and at the Argento level, potentially translate into value that is actually accessible to public unitholders. The wide gap between the DCF value and the founders' transaction is exactly the spread in which all of those steps can still succeed, but can also still erode.
Bottom Line
The right way to read Ayyeka in late 2025 and early 2026 is not "high value versus a skeptical market." It is "control being bought before cash has fully proved itself." That is a very different framing. The founders' deal looks positive because it reduces legal friction and strengthens Argento's hand. But it also reveals the real price of control in an interim period, $5 million paid in stages, with collateral and with rescission risk. The 14% loan looks like a bridge, but it also explains why a bridge was needed in the first place.
So the current thesis is not that Ayyeka is not worth the headline number on paper. It is that the road from that value to accessible value is still long, financed and more fragile than a quick read of the holdings table suggests. If New York turns into cash, if the expensive debt shrinks, and if the new control structure lets Ayyeka operate without continued legal noise, the gap can close quickly. If one of those pieces fails, the large value will turn out to have been real mainly inside the model.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.